These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16636258)

  • 21. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis.
    Haas J; Hommes OR
    Mult Scler; 2007 Aug; 13(7):900-8. PubMed ID: 17881400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis.
    Schwarz A; Korporal M; Hosch W; Max R; Wildemann B
    Neurology; 2010 Jun; 74(24):2022-4. PubMed ID: 20548047
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with gonadotropin-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et al.
    Blumenfeld Z
    Arthritis Rheum; 2002 Sep; 46(9):2542; author reply 2542. PubMed ID: 12355508
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
    Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
    Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of ECT and anesthesia in the setting of multiple sclerosis.
    Fitzsimons MG; Welch CA; Haspel KL; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):195-8. PubMed ID: 17522564
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethanol responsive tremor in a patient with multiple sclerosis.
    Hammond ER; Kerr DA
    Arch Neurol; 2008 Jan; 65(1):142-3. PubMed ID: 18195153
    [No Abstract]   [Full Text] [Related]  

  • 27. Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.
    Gajofatto A; Bacchetti P; Grimes B; High A; Waubant E
    Mult Scler; 2009 Jan; 15(1):50-8. PubMed ID: 18922831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study.
    Lugaresi A; Durastanti V; Gasperini C; Lai M; Pozzilli C; Orefice G; Sotgiu S; Pucci E; Ardito B; Millefiorini E;
    Clin Neuropharmacol; 2008; 31(3):167-72. PubMed ID: 18520983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
    Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of relapses in multiple sclerosis.
    Vollmer T
    J Neurol Sci; 2007 May; 256 Suppl 1():S5-13. PubMed ID: 17346747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
    Leone MA; Bonissoni S; Collimedaglia L; Tesser F; Calzoni S; Stecco A; Naldi P; Monaco F
    Mult Scler; 2008 May; 14(4):485-93. PubMed ID: 18208889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro fertilization in the polycystic ovary syndrome patient: an update.
    Lin K; Coutifaris C
    Clin Obstet Gynecol; 2007 Mar; 50(1):268-76. PubMed ID: 17304041
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding pseudo: the symptoms are real, the cause is unclear.
    Green AJ
    Neurology; 2009 May; 72(19):1626-7. PubMed ID: 19246422
    [No Abstract]   [Full Text] [Related]  

  • 35. Spinchter symptoms as predictors of long-term disability in multiple sclerosis.
    Frazer ML; Benson JT; Hashemi CA; Lee H; Rodman KD; Kolar OJ
    Arch Neurol; 2007 Sep; 64(9):1359; author reply 1359. PubMed ID: 17846283
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of multiple sclerosis relapses with immunomodulating agents.
    Johnson KP
    J Neurol Sci; 2007 May; 256 Suppl 1():S23-8. PubMed ID: 17350652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis.
    Then Bergh F; Kümpfel T; Yassouridis A; Lechner C; Holsboer F; Trenkwalder C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):295-303. PubMed ID: 17224002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
    Rose JW; Burns JB; Bjorklund J; Klein J; Watt HE; Carlson NG
    Neurology; 2007 Aug; 69(8):785-9. PubMed ID: 17709711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Flachenecker P; Meissner H
    Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.